Brief: Bd Strengthens Leadership In Peripheral Vascular Innovation With Positive Agility Trial Results
07/10/2026 13:20
BRIEF-Bd Strengthens Leadership In Peripheral Vascular Innovation With Positive Agility Trial Results Oct 7 (Reuters) - Becton Dickinson and Co BDX.N:
BD STRENGTHENS LEADERSHIP IN PERIPHERAL VASCULAR INNOVATION WITH POSITIVE AGILITY TRIAL RESULTS
Source text: ID:nPn9qFklba
Further company coverage: BDX.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Becton Dickinson and
See all newsBrief: Bd Strengthens Leadership In Peripheral Vascular Innovation With Positive Agility Trial Results
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Becton Dickinson rises after pledging $19 billion US investment for tariff relief
Factbox: Global healthcare companies invest billions to boost US presence
Brief: Becton Dickinson To Invest $19 billion In US